WASHINGTON, June 14, 2017 -- Winning Strategies Washington is pleased to announce that Bobby Clark, a recognized leader in health policy, has joined the firm as Of Counsel.
Bobby most recently served as a Counselor to former Secretary of Health and Human Services Sylvia M. Burwell. In this capacity, he advised Secretary Burwell on policy matters related to public health and science. Bobby worked closely with the Department’s key public health and scientific agencies, including the Food and Drug Administration and the National Institutes of Health and as a policy leader for the Department’s efforts on President Obama’s Precision Medicine Initiative and the Cancer Moonshot Initiative.
Bobby previously served as a health policy advisor in the U.S. House of Representatives from 2003-2010 as a senior staff member of the House Energy and Commerce Committee, Subcommittee on Health and for Representative Frank Pallone, Jr. of New Jersey. Mr. Pallone is currently the Ranking Member of the full Energy and Commerce Committee. During Bobby’s time on Capitol Hill, he contributed to a number of legislative achievements, most notably the Affordable Care Act.
In serving as Of Counsel to the firm, Bobby will be focused on adding new health care clients and expanding service offerings, including detailed policy analysis of health care issues.
“Especially now, when clients have to navigate an immensely complicated health care policy and political landscape, Bobby is an incredible addition to our team. Bobby is also a longstanding friend and colleague, and we are thrilled to bring him back to his Jersey roots,” said Donna Mullins, Managing Partner of the firm.
“This is sort of a homecoming for me. New Jersey is home to so many organizations that are leading the way and innovating in health care. I can’t wait to roll up my sleeves and get to work helping guide clients’ legislative, regulatory and policy objectives,” added Bobby.
Prior to joining HHS, Bobby worked at PwC's Health Research Institute, where he led the Institute’s analysis of regulatory and policy initiatives impacting the pharmaceutical and life sciences industries. While at PwC, Bobby also advised leading healthcare companies on shifting trends in the US health care marketplace.
Contact: Chelsey Penrod Hickman 202-589-0800


BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Bill Ackman Eyes New Fund to Bet Against Market Complacency
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization 



